Intact monoclonal antibodies separation and analysis by sheathless capillary electrophoresis-mass spectrometry.
Capillary electrophoresis
glycoform separation
mass spectrometry
micro-variant separation
monoclonal antibody
Journal
European journal of mass spectrometry (Chichester, England)
ISSN: 1751-6838
Titre abrégé: Eur J Mass Spectrom (Chichester)
Pays: England
ID NLM: 101124748
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
pubmed:
24
10
2018
medline:
10
7
2019
entrez:
24
10
2018
Statut:
ppublish
Résumé
Capillary electrophoresis-mass spectrometry coupling is a growing technique in biopharmaceutics characterization. Assessment of monoclonal antibodies is well known at middle-up and bottom-up levels to obtain information about the sequence, post-translational modifications and degradation products. Intact protein analysis is an actual challenge to be closer to the real protein structure. At this level, actual techniques are time consuming or cumbersome processes. In this work, a 20 minutes separation method has been developed to optimize characterization of intact monoclonal antibodies. Thus, separation has been done on a positively charged coated capillary with optimized volatile background electrolyte and sample buffer. Three world-wide health authorities approved monoclonal antibodies have been used to set up a rapid and ease of use method. Intact trastuzumab, rituximab and palivizumab isoforms have been partially separated with this method in less than 20 minutes under denaturing conditions. For each monoclonal antibody, 2X-glycosylated and 1X-glycosylated structures have been identified and separated. Concerning basic and acidic variants, potential aspartic acid isomerization modification and asparagine deamidation have been observed. Accurate mass determination for high-mass molecular species remains a challenge, but the progress in intact monoclonal antibodies separation appears very promising for biopharmaceutics characterization.
Identifiants
pubmed: 30351978
doi: 10.1177/1469066718807798
doi:
Substances chimiques
Trastuzumab
P188ANX8CK
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM